SF3B1 and glioblastoma: The blockade of SF3B1 activity prevents the AKT/mTOR/ß-catenin pathway and BCL-XL splicing variant; lessens GBM proliferation, migration, tumorsphere formation, and VEGF secretion; and induces apoptosis [93].